Cite
APA Citation
Baz, R. C., Shain, K. H., Hussein, M. A., Lee, J., Sullivan, D. M., Oliver, E. F., Nardelli, L. A., Nodzon, L. A., Zhao, X., Ochoa‐Bayona, J. L., Nishihori, T., Dalton, W. S., & Alsina, M. (n.d.). phase II study of pegylated liposomal doxorubicin, low‐dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma. American journal of hematology, 89(1), 62–67. http://access.bl.uk/ark:/81055/vdc_100024786143.0x000049